Cervical Cancer PDX Models

Patient-derived xenograft (PDX) models display a true representation of the human heterogeneity of gynecologic malignancies and provide the most accurate approach to predicting an agent’s efficacy prior to entering the clinic. The CrownBio cervical cancer PDX collection consists of several models, including models of North American and Asian descent, which are useful for screening novel therapies and potential biomarker discovery. More

PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. CrownBio’s HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.
MODEL NUMBERCANCER SUBTYPE # per page
CV10037 NECCLICK TO VIEW
CV10040 NACLICK TO VIEW
CV10045 NACLICK TO VIEW
CV10054 NACLICK TO VIEW
CV10058 NACLICK TO VIEW
CV10941 NACLICK TO VIEW
CV1248 SCCCLICK TO VIEW
CV1664 SCCCLICK TO VIEW
CV1802 SCCCLICK TO VIEW
CV2320 SCCCLICK TO VIEW
CV3035 SCCCLICK TO VIEW
CV3407 SCCCLICK TO VIEW
CV3560 SCCCLICK TO VIEW
CV3567 SCCCLICK TO VIEW
CV3633 SCCCLICK TO VIEW
CV3649 SCCCLICK TO VIEW
CV3666 SCCCLICK TO VIEW
CV3667 SCCCLICK TO VIEW
CV5105 NECCLICK TO VIEW